Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
64 hedge funds and large institutions have $35.7M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 5 closing their positions.
373% more call options, than puts
Call options by funds: $175K | Put options by funds: $37K
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
7% more funds holding
Funds holding: 60 → 64 (+4)
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
4% less capital invested
Capital invested by funds: $37.2M → $35.7M (-$1.51M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$818K |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$676K |
| 3 |
Renaissance Technologies
New York
|
+$326K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$297K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$110K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.02M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$475K |
| 3 |
Goldman Sachs
New York
|
-$177K |
| 4 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
-$117K |
| 5 |
D.E. Shaw & Co
New York
|
-$85K |
FRTX Hedge Fund Activity: Q4 2014 in Review
64 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q4 2014, worth a combined $35.7M — down 4.1% from $37.2M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new FRTX positions and 5 closed out — a net gain of 5 holders — while 15 added to existing stakes and 14 trimmed.
The largest buyer was RA Capital Management, adding an estimated $818K. The largest seller was Great Point Partners, cutting an estimated $1.02M.
- 64 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q4 2014, up from 60 in Q3 2014.
- Funds reported $35.7M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q4 2014, down 4.1% quarter-over-quarter.
- 10 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q4 2014 and 5 closed out, a net change of +5 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q4 2014 was RA Capital Management, an estimated $818K added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q4 2014 was Great Point Partners, an estimated $1.02M sold.
Based on aggregated 13F filings for Q4 2014.